Related Experiment Videos
Dendritic cell-based therapies in the bench and the bedsides
Sk Md Fazle Akbar1, Hidehiro Murakami, Norio Horiike
1Third Department of Internal Medicine, Ehime University School of Medicine, Japan. akbar@m.ehime-u.ac.jp
Current Drug Targets. Inflammation and Allergy
|September 24, 2004
Summary
Antigen-presenting dendritic cells (DCs) are crucial for immune responses and homeostasis. Research explores their functions and therapeutic potential in various diseases, moving from lab findings to clinical applications.
Area of Science:
- Immunology
- Cell Biology
Background:
- Dendritic cells (DCs) are key leukocytes initiating adaptive immunity and maintaining immune tolerance.
- DCs play vital roles in innate immunity, B-cell development, and homeostasis.
- Dysfunction of DCs is linked to chronic infections, autoimmune diseases, allergies, and cancers.
Purpose of the Study:
- To review the fundamental nature and functions of dendritic cells (DCs).
- To discuss the translation of laboratory findings on DCs to clinical applications.
- To explore the therapeutic potential of DC-based therapies.
Main Methods:
- Literature review of established knowledge on dendritic cell biology.
- Analysis of clinical trial data and preclinical studies on DC-based therapies.
Main Results:
- DCs exhibit diverse functions, including inducing tolerance and initiating innate and adaptive immunity.
- DC dysfunction is implicated in various pathological conditions.
- DC-based therapies show promise in preclinical models and early clinical trials.
Conclusions:
- Understanding DC functions is critical for developing novel therapeutic strategies.
- DC-based therapies hold potential for treating infections, autoimmune disorders, and cancer.
- Further clinical evaluation is needed to establish the efficacy and safety of DC-based treatments.